Cilastatin does not affect Carba NP test performance for detection of carbapenemase production in Enterobacteriaceae
- 01.01.2017
- original article
Erschienen in:
- Verfasst von
- Dr. Rainer Hartl
- Sarah Widhalm
- Dr. Heidrun Kerschner
- Univ. Prof. Petra Apfalter
- Dr. Rainer Gattringer
- Erschienen in
- Wiener klinische Wochenschrift | Ausgabe 1-2/2017
Summary
The Carba NP test is a simple confirmation method for carbapenemase-producing Enterobacteriaceae (CPE) but reagents have to be freshly prepared as imipenem sodium salt is unstable. We evaluated the Carba NP test performance based on a commercially available 10-fold cheaper drug formulation containing cilastatin against 217 CPE and 78 non-CPE isolates with reduced meropenem susceptibility. Specificity and sensitivity were 100 % and 98.6 %, respectively and 3 false negative results of blaVIM-1-producing Proteus mirabilis were reproducible with the RAPIDEC® Carba NP test. Cilastatin does not disturb test performance provided that the imipenem drug quantity is doubled.
Anzeige
- Titel
- Cilastatin does not affect Carba NP test performance for detection of carbapenemase production in Enterobacteriaceae
- Verfasst von
-
Dr. Rainer Hartl
Sarah Widhalm
Dr. Heidrun Kerschner
Univ. Prof. Petra Apfalter
Dr. Rainer Gattringer
- Publikationsdatum
- 01.01.2017
- Verlag
- Springer Vienna
- Erschienen in
-
Wiener klinische Wochenschrift / Ausgabe 1-2/2017
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671 - DOI
- https://doi.org/10.1007/s00508-016-1106-6
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.